Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy.
Saved in:
| Title: | Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy. |
|---|---|
| Authors: | Chen, Dung-Tsa1 (AUTHOR) dung-tsa.chen@moffitt.org, Saltos, Andreas N.2 (AUTHOR) andreas.saltos@moffitt.org, Rose, Trevor3 (AUTHOR) trevor.rose@moffitt.org, Thompson, Zachary J.1 (AUTHOR) ram.thapa@moffitt.org, Thapa, Ram1 (AUTHOR), Chiappori, Alberto2 (AUTHOR) alberto.chiappori@moffitt.org, Gray, Jhanelle E.2 (AUTHOR) jhanelle.gray@moffitt.org |
| Source: | Cancers. May2023, Vol. 15 Issue 9, p2521. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers15092521 |
